MLB Baseball
Scoreboard|Postseason|Stats|Standings|Teams|Players|Player News|Injuries|Transactions

Philadelphia Phillies (80-82)


Wed. 9/26 Thu. 9/27 Fri. 9/28 Sat. 9/29 Sun. 9/30
@ Col 
L 0-14
Box | Recap
@ Col 
L 3-5
Box | Recap
vs. Atl 
L 2-10
Box | Recap
vs. Atl 
W 3-0
Box | Recap
vs. Atl 
W 3-1
Box | Recap

McCutchen, Phillies finalize $50M, 3-year deal

LAS VEGAS (AP) All-Star outfielder Andrew McCutchen and the Philadelphia Phillies finalized a back-loaded $50 million, three-year contract on Wednesday, a deal that includes a team option for 2022.

McCutchen gets $10 million next season, $17 million in 2020 and $20 million in 2021. The Phillies have a $15 million option for 2022 with a $3 million buyout.

The 32-year-old was an All-Star each season from 2011-15, topping .300 in batting average from 2012-14. He was the NL MVP in 2013.

 MORE
Leaders
AVG: O. Herrera.255
HR: R. Hoskins34
RBI: R. Hoskins96
SB: C. Hernández19
W: A. Nola17
ERA: A. Nola2.37
Saves: S. Domínguez16
K: A. Nola224
General Batting (Rank)
AVG: .234 (30)
Runs: 677 (22)
Hits: 1270 (30)
Home Runs: 186 (15)
Stolen Bases: 69 (23)
OBP: .314 (19)
SLG: .393 (23)
Total Bases: 2129 (25)
General Pitching (Rank)
Earned Run Average: 4.14 (18)
Runs Allowed: 728 (19)
Saves: 44 (11)
Strikeouts: 1465 (6)
OpBA: .249 (16)
OBP: .316 (14)
SLG: .407 (14)
Run Support: 4.21 (22)
Transactions
Date Player Transactions
12/12 A. McCutchen Signed as Free Agent ( 2019-2021; Opt 2022)(three-year contract)
12/6 J. Álvarez Traded Los Angeles (for RHP Luis Garcia)
12/3 J. Nicasio Traded Seattle (for 1B Carlos Santana, five-player deal)
12/3 J. Pazos Traded Seattle (for 1B Carlos Santana, five-player deal)
12/3 J. Segura Traded Seattle (for 1B Carlos Santana, five-player deal)
Show Transactions
Injuries
Date Player Status
9/11 M. Franco Shoulder contusion (day-to-day)
9/11 J. Segura Illness (day-to-day)
9/7 R. Quinn Right foot (day-to-day)
8/26 R. Quinn Left hamstring (day-to-day)
8/23 J. Bour off 10-day DL
Show Injuries

Sports Data API Powered by STATS © 2018 by STATS.
Any commercial use or distribution without the express written consent of STATS is strictly prohibited.